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Summary The objectives were to describe a case of a patient with acute ischemic stroke who
achieved recanalization of the occluded middle cerebral artery and a good clinical improvement
after immediate application of standard medical treatment (including aspirin) plus sonothrom-
bolysis for 2 h without use of rt-PA. After the ﬁrst 24 h, a rare form of aphasia, a semantic type of
aphasia was described. On day 5, the NIHSS score of the patient was 2, on day 30, his NIHSS and
modiﬁed Rankin score was 0. The main factors inﬂuencing favorable outcome were discussed.
Despite controversial evidence, it is worth studying the efﬁcacy and safety of sonothrombolysis
without rt-PA, but with commonly used drugs. This approach could be easily applied in eligible
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Introduction
The ultrasound energy could increase the intrinsic ﬁbrinoly-
sis in occluded vessels even in the absence of thrombolytic
agents, such as alteplase (rt-PA) [1—5]. The results of CLOT-
BUST clinical trials showed that the sonothrombolysis (STL)
or the combination of rt-PA plus 2 h of continuous transcra-
nial Doppler (TCD) was able to increase recanalization rates
in acute ischemic stroke (AIS), with a trend toward better
functional outcomes compared to rt-PA alone [6]. Sponta-
neous recanalization of the middle cerebral artery (MCA) in
Abbreviations: rt-PA, recombinant tissue plasminogen activa-
tor; STL, sonothrombolysis; TCD, transcranial Doppler; AIS, acute
ischemic stroke; MCA, middle cerebral artery; TIBI, thrombolysis in
brain ischemia; TL, thrombolysis; TCCDS, transcranial color-coded
duplex sonography; PSV/EDV, peak systolic/end diastolic velocity.
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IS was observed despite a poor initial thrombolysis in Brain
schemia (TIBI) score in some patients who were not eligi-
le for (or not treated with) thrombolysis (TL) using rt-PA
2,7—10]. The factors leading to spontaneous recanaliza-
ion, its natural rate, and whether STL without rt-PA should
e worth doing in large clinical series or is potentially inef-
ective, are still unresolved questions.
The objectives of the current report were to describe a
ase of a patient who suffered AIS and achieved good clin-
cal improvement after immediate application of standard
edical treatment plus STL for 2 h (transcranial color-coded
uplex sonography) without use of rt-PA.
aterials and methods
59-year old patient presented in the emergency room with
Open access under CC BY-NC-ND license.ight hemiplegia and complete motor aphasia 1.5 h after he
as found earlier in the morning. The exact time of his
troke onset was not known, but according to his wife, it
as deﬁnitely between 2 and 6 h before the admission.
-ND license.










































































iFigure 1 Minute 30.
On admission, the patient had a NIHSS score of 10, and
lood pressure of 150/80mmHg. From the past medical
istory, he had only mild arterial hypertension, treated
ith beta-blocker. The routine blood tests, ECG, and con-
entional computed tomography (CT) of the head were
arried out (according to the Bulgarian AIS guideline). When
he diagnosis of AIS was accepted after CT, the patient
as given immediately aspirin 300mg, bisoprolol 5mg,
torvastatin 10mg orally; normal saline 0.9% 1.5 L, pyrac-
tam (Nootropil) 3.0 g intravenously; and fraxiparine 0.4mL
ubcutaneously. The values of his complete blood count, bio-
hemistry and lipids panel were within normal limits, except
or the leucocytes count of 13.3× 109/l and hematocrit of
.54.
The extracranial and transcranial color-coded duplex
onography (TCCDS) was performed after admission in the
troke unit. The exact vessel pathology and hemodynamic
tatus were deﬁned in accordance to TIBI and COGIF crite-
ia [7,11—14] using General Electric Vivid 7 Pro diagnostic
CCDS device. The extracranial ultrasound showed mild
theromatous carotid changes with higher intima—media
hickness complex values bilaterally and several small
ypoechogenic nonstenotic plaques around the bifurcations.
n TCCDS, there was evidence of occlusion in the left MCA,
ts proximal M1 segment. Signals from corresponding A1,
1 and C1 segments of the basal cerebral arteries were
ecorded as needed [13]. The monitoring of intracranial
elocities and STL of the left MCA were done by manually
olding a 2-MHz transducer for 2 h via transtemporal win-
ow (sample volume 5mm, low velocity scale; broad color
uplex window to be able to see A1, C1, P1 arteries; mild
scillations and adjustments along the course of affected M1
egment). The neurologic and hemodynamic status of the
atient was assessed after 3, 6, and 12 h, as well as on the
st, 3rd, 5th, 30th, and 90th day by a neurologist, speech
herapist and neurosonologist.
esultsn starting TCCDS monitoring (minute 0), there was not
ny detectable signal from the initial M1 segment of MCA,
IBI scale score 0. From minute 30 (Fig. 1) until minute
20, a minimal, spike-like MCA ﬂow occurred, with peak
p
r
WFigure 2 Day 1.
ystolic/end diastolic velocity (PSV/EDV) 20/5 cm/s, and
IBI score was between 1 and 2. Respectively, TIBI 3 was
etected on the sixth hour with a dampened MCA ﬂow
attern and PSV/EDV 50/24 cm/s. On the ﬁrst day, MCA
SV/EDV were 68/26 cm/s (Fig. 2). On the third day, there
as no signiﬁcant asymmetry between the two MCA arter-
es, with PSV/EDV of 76/40 cm/s, TIBI 5 score. On day 30,
lood ﬂow velocities of both MCAs were within normal range
Figs. 3—7).
The patient’s neurological status improved on the ﬁrst
ay after admission. His NIHSS score changed from 10 to 5,
nd his complete motor aphasia resolved to a semantic one.
his particular and rare type of aphasia was characterized
y impaired simultant gnosis, comprehension of time rela-
ions, and constructions of afﬁliations, such as ‘‘my father’s
rother is my. . .’’. This rare type of aphasia (described ﬁrst
y Russian neuropsychologist A.R. Luria) is not included in
ll modern classiﬁcations. It is thought to be a part of the
ensory aphasia [15].
On discharge at day 5, the NIHSS score of the patient was
. On the follow-up at the ﬁrst month the patient achieved
omplete neurological recovery. At the third month his mod-
ﬁed Rankin Scale was 0.
iscussion and conclusion
he acute occlusion of the proximal MCA segment is a dan-
erous event that could lead to a large brain infarct, severe
isability, and poor functional outcome in cases with no
ecanalization [9,10]. That is why we applied STL 3.5—6 h
fter the onset of AIS. We observed the evolution of recanal-
zation in the occluded MCA within the ﬁrst 6—12 h after the
rocedure [8,16]. In the presented case, two rare clinical sit-
ations deserve attention. First, the favorable outcome was
chieved using simple and non-expensive treatment includ-
ng STL without rt-PA. Second, there was a quick resolution
f an almost complete motor aphasia to a speciﬁc seman-
ic type that was connected to the location of the brain
schemic changes in MCA territory and their functional com-
ensation.
The quick clinical improvement of our patient could be a
esult of mere chance for spontaneous recanalization [9,10].
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after CT, and approximately 3.5 h after the stroke onset) was
an important factor for the disease evolution and long-term
prognosis [17]. Based only on a single observation, it would
be a speculative suggestion to accept that 2 h of STL com-
bined with 300mg aspirin given orally contributed to the
mechanical breakdown of thrombus and recanalization in
the left MCA. The data from a clinical study showed evidence
toward better recanalization rate in patients not eligible
for IV rt-PA [2,8]. However, the role of other medications
given to those patients, their dosages and time of adminis-
tration along with the STL was not clear as a contributing
factor.
In some acute clinical presentations with unknown time
of stroke onset, still there are no reliable criteria to dis-
tinguish who would beneﬁt from TL and who would beneﬁt
from STL. Perhaps, younger age, lower initial NIHSS score,
MRI mismatch and TIBI scale or COGIF grade improve-
ments could be used as favorable prognostic parameters
[4,11—13,16,18].
Despite controversial evidence in literature
[1,2,5,10—12], we think that it is worth studying the
efﬁcacy and safety of this simple method, TCCDS STL
without TL agent, but with aspirin or other commonly used
drugs. This approach could be easily applied in eligible
patients almost in every stroke unit facility worldwide.
Appendix A. Supplementary data
Supplementary data associated with this article can
be found, in the online version, at http://dx.doi.org/
10.1016/j.permed.2012.03.018.
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